Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection

Viral Immunology

Volumn 23, Issue 5, 2010, Pages 487-495

  Frazier, Ashley D ^b   Zhang, Chun L ^b   Ni, Lei ^b   Ma, Cheng J ^b   Zhang, Ying ^b   Wu, Xiao Y ^b   Atia, Antwan N ^b   Yao, Zhi Q ^a,b   Moorman, Jonathan P ^a,b  

^a James H Quillen VA Medical Center   (United States)

^b East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CORE PROTEIN; PROGRAMMED DEATH 1 LIGAND 1; RECEPTOR ANTIBODY; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS INFECTION;

ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOBLOTTING; PROGRAMMED CELL DEATH 1 RECEPTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 77957747850     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0010     Document Type: Article

References (27)

1. King E, Trabue C, Yin D, Yao ZQ, and Moorman JP: Hepatitis C: the complications of immune dysfunction. Exp Rev Clin Immunol 2007;3:145-157.
2. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, and Chisari FV: Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in subjects with chronic hepatitis C virus infection. J Clin Invest 1996;98:1432-1440.
3. Chang KM, Rehermann B, McHutchison JG, Pasquinelli C, Southwood S, Sette A, and Chisari FV: Immunological significance of cytotoxic T lymphocyte epitope variants in subjects chronically infected by the hepatitis C virus. J Clin Invest 1997;100:2376-2385.
4. Wedemeyer H, He XS, Nascimbeni M, et al.: Impaired effector function of hepatitis C virus specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002;169:3447-3458.
5. Lechmann M, Woitas RP, Langhans B, et al.: Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis Can J Hepatol 1999;31:971-978.
6. Eisen-Vandervelde A, Yao ZQ, and Hahn YS: The molecular basis of HCV-mediated immune dysregulation. Clin Immunol 2004;111:16-21.
7. Yao ZQ, Ray S, Eisen-Vandervelde A, Waggoner S, and Hahn YS: Hepatitis C virus: Immunosuppression by complement regulatory pathway. Viral Immunol 2001;14:277-295.
8. Nishimura H, and Honjo T: PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 2001;22:265-268.
9. Okazaki T, and Honjo T: PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 2007;19:813-824.
10. Alexander WS: Suppressors of cytokine signaling (SOCS) in the immune system. Nat Rev Immunol 2002;2:410-416.
11. Penna A, Pilli M, Zerbini A, et al.: Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 2007;45:588-601.
12. Golden-Mason L, Palmer B, Klarguist J, Mengshol JA, Gastelblanco N, and Rosen HR: Upregulation of PD-1 expression on circulating and hepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 2007;81:9249-9258.
13. Golden-Mason L, Klarguist J, Wahed AS, and Rosen HR: Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy, race-dependent differences. J Immunol 2008;180:3637-3641.
14. Miyoshi H, Fujie H, Shintani Y, et al.: Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS) -. gene expression. J Hepatol 2005;43:757-763.
15. Vlotides G, Sörensen AS, Kopp F, et al.: SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2, 5-OAS and MxA. Biochem Biophys Res Commun 2004;320:1007-1014.
16. Kittlesen DJ, Chianese-Bullick KA, Yao ZQ, Braciale TJ, and Hahn YS: Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T lymphocyte proliferation. J Clin Invest 2000;106:1239-1249.
17. Yao ZQ, Nguyen DT, Hiotellis AI, and Hahn YS: Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J Immunol 2001;167:5264-5272.
18. Yao ZQ, Eisen-Vandervelde A, Ray S, and Hahn YH: HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27kip1. Virology 2003;314:271-282.
19. Yao ZQ, Eisen-Vandervelde A, Waggoner SN, Cale EM, and Hahn YS: Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. J Virol 2004;78:6409-6419.
20. Yao ZQ, Prayther D, Trabu C, Dong ZP, and Moorman J: Differential regulation of SOCS-1 signaling in T and B lymphocytes by HCV core protein. Immunology 2008;125:197-207.
21. Yao ZQ, King E, Prayther D, Yin D, Zhang Y, and Moorman JP: T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling. Viral Immunol 2007;20:276-287.
22. Moorman JP, Dong ZP, Ni L, Zhang CL, Borthwick T, and Yao ZQ: Abnormal B lymphocyte activation associated with TALL-1 overexpression and SOCS-1 deregulation in chronic HCV infection. Immunology 2009;128:227-235.
23. Helbig KJ, Yip E, McCartney EM, Eyre NS, and Beard MR: A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylation. Antiviral Res 2008;77:169-176.
24. Kondo Y, Sung VM, Machida K, Liu M, and Lai MM: Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology 2007;361:161-173.
25. Frey KG, Ahmed C M I, Dabelic R, et al.: HSV1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion. J Immunology 2009;183:1253-1262.
26. Hashimoto K, Ishibashi K, Ishioka K, et al.: RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules. Virology 2009;391:162-170.
27. Yadav A, Fitzgerald P, Sajadi MM, Gilliam B, Lafferty MK, Redfield R, and Reid W: Increased expression of suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated T helper-1 responses in HIV disease. Virology 2003;385:126-133.